CNBC’s David Faber reports on the rapid rise of Eastman Kodak shares after the storied photography company received a $765 million loan to create drug chemicals to help combat the coronavirus pandemic.
CNBC’s David Faber reports on the rapid rise of Eastman Kodak shares after the storied photography company received a $765 million loan to create drug chemicals to help combat the coronavirus pandemic.